Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 58

1.

SOX11 identified by target gene evaluation of miRNAs differentially expressed in focal and non-focal brain tissue of therapy-resistant epilepsy patients.

Haenisch S, Zhao Y, Chhibber A, Kaiboriboon K, Do LV, Vogelgesang S, Barbaro NM, Alldredge BK, Lowenstein DH, Cascorbi I, Kroetz DL.

Neurobiol Dis. 2015 May;77:127-40. doi: 10.1016/j.nbd.2015.02.025. Epub 2015 Mar 10.

PMID:
25766675
2.

Prehospital use of magnesium sulfate as neuroprotection in acute stroke.

Saver JL, Starkman S, Eckstein M, Stratton SJ, Pratt FD, Hamilton S, Conwit R, Liebeskind DS, Sung G, Kramer I, Moreau G, Goldweber R, Sanossian N; FAST-MAG Investigators and Coordinators.

N Engl J Med. 2015 Feb 5;372(6):528-36. doi: 10.1056/NEJMoa1408827.

PMID:
25651247
3.

De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies.

EuroEPINOMICS-RES Consortium; Epilepsy Phenome/Genome Project; Epi4K Consortium.

Am J Hum Genet. 2014 Oct 2;95(4):360-70. doi: 10.1016/j.ajhg.2014.08.013. Epub 2014 Sep 25.

4.

Delayed recurrence of intracranial chordoma.

Alldredge BR, Meers GW.

Optom Vis Sci. 2014 Mar;91(3):e76-82. doi: 10.1097/OPX.0000000000000155.

PMID:
24413277
5.

In reply.

Alldredge BK, Kayser SR.

JAMA Intern Med. 2013 Aug 12;173(15):1473. No abstract available.

PMID:
24151653
6.

Lennox-Gastaut syndrome of unknown cause: phenotypic characteristics of patients in the Epilepsy Phenome/Genome Project.

Widdess-Walsh P, Dlugos D, Fahlstrom R, Joshi S, Shellhaas R, Boro A, Sullivan J, Geller E; EPGP Investigators.

Epilepsia. 2013 Nov;54(11):1898-904. doi: 10.1111/epi.12395. Epub 2013 Oct 7.

PMID:
24116958
7.

De novo mutations in epileptic encephalopathies.

Epi4K Consortium; Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF, Cossette P, Delanty N, Dlugos D, Eichler EE, Epstein MP, Glauser T, Goldstein DB, Han Y, Heinzen EL, Hitomi Y, Howell KB, Johnson MR, Kuzniecky R, Lowenstein DH, Lu YF, Madou MR, Marson AG, Mefford HC, Esmaeeli Nieh S, O'Brien TJ, Ottman R, Petrovski S, Poduri A, Ruzzo EK, Scheffer IE, Sherr EH, Yuskaitis CJ, Abou-Khalil B, Alldredge BK, Bautista JF, Berkovic SF, Boro A, Cascino GD, Consalvo D, Crumrine P, Devinsky O, Dlugos D, Epstein MP, Fiol M, Fountain NB, French J, Friedman D, Geller EB, Glauser T, Glynn S, Haut SR, Hayward J, Helmers SL, Joshi S, Kanner A, Kirsch HE, Knowlton RC, Kossoff EH, Kuperman R, Kuzniecky R, Lowenstein DH, McGuire SM, Motika PV, Novotny EJ, Ottman R, Paolicchi JM, Parent JM, Park K, Poduri A, Scheffer IE, Shellhaas RA, Sherr EH, Shih JJ, Singh R, Sirven J, Smith MC, Sullivan J, Lin Thio L, Venkat A, Vining EP, Von Allmen GK, Weisenberg JL, Widdess-Walsh P, Winawer MR.

Nature. 2013 Sep 12;501(7466):217-21. doi: 10.1038/nature12439. Epub 2013 Aug 11.

8.

The epilepsy phenome/genome project.

EPGP Collaborative, Abou-Khalil B, Alldredge B, Bautista J, Berkovic S, Bluvstein J, Boro A, Cascino G, Consalvo D, Cristofaro S, Crumrine P, Devinsky O, Dlugos D, Epstein M, Fahlstrom R, Fiol M, Fountain N, Fox K, French J, Freyer Karn C, Friedman D, Geller E, Glauser T, Glynn S, Haas K, Haut S, Hayward J, Helmers S, Joshi S, Kanner A, Kirsch H, Knowlton R, Kossoff E, Kuperman R, Kuzniecky R, Lowenstein D, McGuire S, Motika P, Nesbitt G, Novotny E, Ottman R, Paolicchi J, Parent J, Park K, Poduri A, Risch N, Sadleir L, Scheffer I, Shellhaas R, Sherr E, Shih JJ, Shinnar S, Singh R, Sirven J, Smith M, Sullivan J, Thio LL, Venkat A, Vining E, von Allmen G, Weisenberg J, Widdess-Walsh P, Winawer M.

Clin Trials. 2013 Aug;10(4):568-86. doi: 10.1177/1740774513484392. Epub 2013 Jul 1.

PMID:
23818435
9.

Polymicrogyria-associated epilepsy: a multicenter phenotypic study from the Epilepsy Phenome/Genome Project.

Shain C, Ramgopal S, Fallil Z, Parulkar I, Alongi R, Knowlton R, Poduri A; EPGP Investigators.

Epilepsia. 2013 Aug;54(8):1368-75. doi: 10.1111/epi.12238. Epub 2013 Jun 10.

10.

Bending the curve toward increased use of generic drugs.

Alldredge BK, Kayser SR.

JAMA Intern Med. 2013 Feb 11;173(3):233-4. doi: 10.1001/jamainternmed.2013.1777. No abstract available.

PMID:
23303368
11.

Evidence for a shared genetic susceptibility to migraine and epilepsy.

Winawer MR, Connors R; EPGP Investigators.

Epilepsia. 2013 Feb;54(2):288-95. doi: 10.1111/epi.12072. Epub 2013 Jan 7.

12.

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months.

Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Adamson PC; Childhood Absence Epilepsy Study Team.

Epilepsia. 2013 Jan;54(1):141-55. doi: 10.1111/epi.12028. Epub 2012 Nov 21.

13.

Treatment of status epilepticus: an international survey of experts.

Riviello JJ Jr, Claassen J, LaRoche SM, Sperling MR, Alldredge B, Bleck TP, Glauser T, Shutter L, Treiman DM, Vespa PM, Bell R, Brophy GM; Neurocritical Care Society Status Epilepticus Guideline Writing Committee.

Neurocrit Care. 2013 Apr;18(2):193-200. doi: 10.1007/s12028-012-9790-1.

PMID:
23097138
14.

The Epilepsy Phenome/Genome Project (EPGP) informatics platform.

Nesbitt G, McKenna K, Mays V, Carpenter A, Miller K, Williams M; EPGP Investigators.

Int J Med Inform. 2013 Apr;82(4):248-59. doi: 10.1016/j.ijmedinf.2012.03.004. Epub 2012 May 10.

15.

Guidelines for the evaluation and management of status epilepticus.

Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM; Neurocritical Care Society Status Epilepticus Guideline Writing Committee.

Neurocrit Care. 2012 Aug;17(1):3-23. doi: 10.1007/s12028-012-9695-z.

PMID:
22528274
16.

Effects of a multicentre teamwork and communication programme on patient outcomes: results from the Triad for Optimal Patient Safety (TOPS) project.

Auerbach AD, Sehgal NL, Blegen MA, Maselli J, Alldredge BK, Vittinghoff E, Wachter RM.

BMJ Qual Saf. 2012 Feb;21(2):118-26. doi: 10.1136/bmjqs-2011-000311. Epub 2011 Nov 7.

PMID:
22069113
17.

Republished paper: Improving safety culture on adult medical units through multidisciplinary teamwork and communication interventions: the TOPS Project.

Blegen MA, Sehgal NL, Alldredge BK, Gearhart S, Auerbach AA, Wachter RM.

Postgrad Med J. 2010 Dec;86(1022):729-33. doi: 10.1136/qshc.2008.031252rep.

PMID:
21106808
18.

Improving safety culture on adult medical units through multidisciplinary teamwork and communication interventions: the TOPS Project.

Blegen MA, Sehgal NL, Alldredge BK, Gearhart S, Auerbach AA, Wachter RM.

Qual Saf Health Care. 2010 Aug;19(4):346-50. doi: 10.1136/qshc.2008.031252.

PMID:
20693223
19.

Brimonidine hypersensitivity when switching between 0.2% and 0.15% formulations.

Sullivan-Mee M, Pensyl D, Alldredge B, Halverson K, Gerhardt G, Qualls C.

J Ocul Pharmacol Ther. 2010 Aug;26(4):355-60. doi: 10.1089/jop.2009.0153.

PMID:
20653479
20.

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.

Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Capparelli EV, Adamson PC; Childhood Absence Epilepsy Study Group.

N Engl J Med. 2010 Mar 4;362(9):790-9. doi: 10.1056/NEJMoa0902014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk